Chapter 1. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– By Product Type

6.1. Insulin      

6.2. Monoclonal Antibodies    

6.3. Growth Factors    

6.4. Interferons            

6.5. Recombinant Proteins      

6.6. Vaccines  

Others     

Chapter 7. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– By Therapeutic Area

7.1. Infectious Disease              

7.2. Cardiovascular Disease      

7.3. Oncology

7.4. Metabolic Disease              

7.5. Respiratory Disorder          

7.6. Autoimmune Disease        

7.7. Neurology              

7.8. Ophthalmology    

7.9. Others   

Chapter 8. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– By Application

8.1. Clinical      

8.2. Commercial         

Chapter 9. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample